baber/WOPTO huggingface dataset:
Patent PT-839122-E (PT)
Inventor: BOIRE PHILIPPE
IPC: G02B1/115
Filed: 1997-05-14
Abstract: PCT No. PCT/FR97/00857 Sec. 371 Date May 14, 1998 Sec. 102(e) Date May 14, 1998 PCT Filed May 14, 1997 PCT Pub. No. WO97/43224 PCT Pub. Date Nov. 20, 1997The invention relates to a glazing pane having an "A" antireflection coating on at least one of its external faces, which antireflection coating comprises a stack of layers of materials having alternately high and low refractive indices. At least some of the layers of the said stack are pyrolysed layers, especially the final layer.
Patent PT-915866-E (PT)
Inventor: BUTLER DONALD EUGENE
IPC: C07D307/33
Filed: 1997-07-01
Abstract: PCT No. PCT/US97/11654 Sec. 371 Date Jan. 27, 1999 Sec. 102(e) Date Jan. 27, 1999 PCT Filed Jul. 1, 1997 PCT Pub. No. WO98/04543 PCT Pub. Date Feb. 5, 1998The invention is an improved process for the preparation of a compound of formula I wherein R and R1 are each independently alkyl of from 1 to 3 carbon atoms; and R2 is alkyl of from 1 to 8 carbon atoms.
Patent PT-875146-E (PT)
Inventor: BURRELL ROBERT EDWARD
IPC: A01N59/26
Filed: 1994-11-01
Abstract: Anti-microbial coatings and powders and method of forming same on medical devices are provides. The coatings are preferably formed by depositing an anti-microbial biocompatible metal by vapour deposition techniques to produce atomic disorder in the coating such that a sustained release of metal ions sufficient to produce an anti-microbial effect is achieved. Preferred deposition conditions to achieve atomic disorder include a lower than normal substrate temperature, and one or more of a higher than normal working gas pressure and a lower than normal angle of incidence of coating flux. Anti-microbial powders formed by vapour deposition or altered by mechanical working to produce atomic disorder are also provided. The anti-microbial effect of the coatings or powders may be further activated or enhanced by irradiating with a low linear energy transfer form of radiation such as gamma radiation. Novel anti-microbial silver materials are defined, characterized by having a positive rest potential, a Trec/Tm less than 0.33, and a grain size less than 200 nm. Anti-microbial fine grain or nanocrystalline materials are provided, together with methods of preparation, wherein the anti-microbial metal if deposited in a matrix with atoms or molecules of a different material such as other biocompatible metals (ex. Ta), trapped or absorbed oxygen, or compounds of anti-microbial metals or biocompatible metals (ex. Ag0 or TaO). The invention also extends to a method of producing an anti-microbial effect with silver materials that form complex silver ions other than Ag<+>, Ag<2+> and Ag<3+>.
Patent PT-960778-E (PT)
Inventor: BEIER HERBERT
IPC: B60R7/04
Filed: 1999-05-26
Abstract: The cover comprises several flat elements (12) connected together for articulated movement and movable in a guide from the closed to open position. The flat elements each have at least two guide projections (22) which define a swivel axis and whose axis is off-set opposite an articulated connection (16) with the adjoining flat element. In the open position the flat elements are set zig-zag relative to each other and in the closed position they lie flat.
Patent PT-1036508-E (PT)
Inventor: HALDEN JONAS PETER
IPC: A23P30/10
Filed: 1999-03-16
Abstract: An injection moulded pasta product and its manufacturing process.
Patent PT-1005471-E (PT)
Inventor: UNVERFERTH KLAUS
IPC: A61K31/505
Filed: 1999-06-04
Abstract: The invention relates to pyrazolo[3,4d]pyrimidin-4(5H)-ones and pyrazolo[3,4-d]pyrimidine-4(5H)-thiones and their tautomers and pharmaceutically acceptable salts, which contain a benzyl radical in the 2-position, processes for their preparation and their use as medicaments, in particular for the treatment of epilepsies of various forms and of allergic/asthmatic diseases.
Patent PT-1089858-E (PT)
Inventor: SVEDBERG BJORN
IPC: E04G21/02
Filed: 1999-06-24
Abstract: Magnetizable fibers dispersed in a viscous body, particularly reinforcing metal fibers dispersed in a wet cementitious material, is carried out by providing a fiber aligning member (15) having a nonmagnetic wall (17) including a first wall portion (17A) and a second wall portion (17B), moving the aligning member (15) relative to the viscous body with the first wall portion (17A) leading and the second portion (17B) trailing it and with the first and second wall portions (17A, 17B) contacting the viscous body, and directing a magnetic field into the viscous body through the first wall portion (17A) to subject the fibers (F) to a moving magnetic field. A device for performing the method comprises: a fiber aligning member (15) having a nonmagnetic wall (17) including a first wall portion (17A) and a second wall portion (17B); and a magnet device (18) disposed adjacent the first wall portion (17A) for directing a magnetic field into the viscous body through the first wall portion (17A), and a manipulating device (14) for moving the fiber aligning member (15) relative to the viscous body with the first wall portion (17A) ahead of the second wall portion (17B) and with the first and second wall portions (17A, 17B) contacting the viscous body.
Patent SG-2892-G (SG)
Title: Floating semirigid pavement
IPC: E01C23/10
Filed: 1992-01-09
Abstract: A pavement constituted by mass or reinforced concrete-molded pieces, arranged the one close to the other in order to form a surface (1) with the necessary amplitude. Each piece, of a regular polygon section, has a flat surface (1) and an inner cavity (3) connected to the surface (1) by a drilling (2) and being open by its base (10). The base (10) has its surface inclined towards the geometrical centre. The pieces are resting on a sand layer (13). Their inner cavity (3) is filled with a sand mass which is injected through the drilling (2) that connects it to the upper part, said drilling being closed with an elastic plug (11). There is a groove (9) around each piece to fit a joint which serves as junction and support between pieces.
Patent SG-8189-G (SG)
Title: Shielded electrical connector
IPC: H01R13/658
Filed: 1989-02-13
Abstract: An elelctrical connector including a shield (13, 14) with a one-piece base member (14) having a cable braid connecting portion comprising a panel (71) from respective opposite sides and the rear of which upstand flanges (69, 70) formed with cable-receiving apertures (73, 74) opening away from the panel (71). Each aperture (73, 74) has inturned cable gripping lips (75). A closure member (13) is provided for latching receipt on the base member (14) with a detent action. A terminal housing (15) received between the base and closure members (13, 14) and has hood (91) and platform portions (82) providing supports for contact portions (79, 67) of the shield at a mating face.
Patent IE-32674-L (IE)
Title: Sulphanilamide derivatives
IPC: C07D235/30
Filed: 1969-03-13
Abstract: 1,261,572. Imidazolidine derivatives; preparation thereof. J. R. GEIGY A.G. 14 March, 1969 [14 March, 1968 (4)], No. 13508/69. Heading C2C. Compounds I (including salts thereof) wherein R 1 signifies C 1-5 alkyl, or an optionally alkyl-substituted cycloalkyl or cycloalkenyl group, or a cycloalkyl-alkyl or cycloalkenylalkyl group of not more than 7 carbons are prepared: (a) by reacting a compound II (wherein R 2 signifies H, Me aryl-, diaryl- or triaryl-methyl, or allyl and X is a group which can be converted by reduction, reductive cleavage or hydrolysis into NH 2 or if R 2 is H, X can be NH 2 ) with a reactive derivative of cyanic acid; (b) by reacting a compound III with a nitrile, R 1 NH.CN, or alkali or alkaline earth metal salt thereof (X is NH 2 or a group which can be converted by reduction, reductive cleavage or hydrolysis into NH 2 ); (c) by reacting a benzene sulphonamide, X.C 6 H 4 .SO 2 NH 2 , with a reactive ester (e.g. a halide) of a hydroxy compound, CH 2 .OH.CH 2 N(R 1 ).CN {X is as defined in (b)}; (d) by reacting an amine, R 1 .NH 2 with a reactive ester of a compound VII (e.g. a bromide) wherein X<SP>1</SP> is a residue which can be converted by hydrolysis, reductive cleavage or reduction into NH 2 ; (e) by heating an acid addition salt IX (Y is halogen); (f) by reducing a compound X in which R 1 <SP>1</SP> signifies C 3-5 alkenyl or optionally alkyl-substituted cycloalkenyl or cycloalkenylalkyl and X is as defined in (b); (g) by reacting a compound XI with a reactive diester of ethylene glycol; and (h) by reacting a compound XII with a reactive ester of a hydroxy compound R 1 OH. Compounds II, III, VII, IX, X, XI and XII are in general prepared by standard methods. Intermediates to compounds I, e.g. compounds wherein in place of NH 2 in I there is an NO 2 - or Me.CO.NH- group, may be produced by methods (a) to (h). N<SP>1</SP> - cyano - N4 - acetyl - sulphanilamide (as the sodium salt) is obtained by the interaction of disodium cyanamide and N-acetyl-sulphanilyl chloride. 4 - (2 - Imidazoline - 2 - ylsulphamoyl) - acetanilide is obtained by the interaction of N- acetyl-sulphanilyl chloride and 2-amino-2-imidazoline hydrochloride. Pharmaceutical preparations showing hypoglycaemic action contain I as active ingredient; administration may be orally or parenterally.
[GB1261572A]
Patent IE-820501-L (IE)
Title: Laminated windscreen.
IPC: B32B17/10
Filed: 1982-03-05
Abstract: A thermoplastic synthetic high polymer sheet including induced tensile stress lengthwise of the sheet which varies in intensity from a maximum along one edge to a minimum along the other edge. The induced tensile stress is frozen in the sheet by maintaining its temperature below a transformation temperature. Upon elevation of the temperature of the sheet above the transformation temperature, as the process of fabrication of a laminated windshield is to commence, the sheet, without further operative forming operations, will deform to conform substantially to the outline of the outer curved lamina of the windshield. The sheet may include a zone along one edge to provide filtering of glare.
Patent IE-42972-L (IE)
Title: Drainage plates for cheese moulds
IPC: A01J25/16
Filed: 1976-04-02
Abstract: A perforated drainage plate for use as a lining in a cheese mould has parallel strips punched out of the plane of the plate to one side thereof to form two narrow slots on each side of each strip with the ends of the strips merging smoothly into the undeformed part of the plate. The plate is arranged with the strips abutting against the wall of the mould so that a narrow passageway is formed between the undeformed portion of the plate and the wall of the mould for draining away when forced through the slots. The strips are aligned in the direction in which a cheese block slides out of the mould after removal therefrom. The angle of inclination of the ends of the strips relative to the adjacent portion of the plate does not exceed 30 degrees, the width of the slots does not exceed 0.6 mm, and the radius of curvature of the recessed surfaces of each strip is not less than 1 mm.
[US4157680A]
Patent FI-820240-L (FI)
Inventor: NEDELEC LUCIEN
IPC: C07J41/00
Filed: 1982-01-26
Abstract: A novel process for the preparation of 17 beta -hydroxyacetyl-17 alpha -ol-steroids of the formula    <IMAGE>  I  wherein R1 is selected from the group consisting of hydrogen, alkyl of 1 to 4 carbon atoms optionally substituted with halogen or an oxygen or nitrogen function and alkenyl and alkynyl of 2 to 4 carbon atoms, R2 is alkyl of 1 to 4 carbon atoms and the A,B,C and D rings may contain one or more double bonds and are optionally substituted with at least one member of the group consisting of hydroxy, keto, halogen, alkyl and alkoxy of 1 to 4 carbon atoms and alkenyl and alkynyl of 2 to 4 carbon atoms which compounds are generally known of the cortisonic type with known properties.
Patent FI-850733-L (FI)
Inventor: LACROIX GUY
IPC: A01N57/22
Filed: 1985-02-22
Abstract: Phosphonic acid diesters having the formula:   <IMAGE>  in which R represents a hydrogenolysable group, preferably an aralkyl group, and R<1> represents a hydrolysable group, are obtained by a process wherein phosphonic acid esters of the formula (R<1>O)2P(O)H are reacted with formaldehyde and compounds of the formula R-NH-CH2-COOH, R and R<1> having the meanings given above. Compounds of the formula   <IMAGE> may be obtained by hydrogenolysis of the above compounds.
Patent IE-871033-L (IE)
Title: Tetrahydrofuran-triazole or imidazole fungicides
IPC: C07D307/18
Filed: 1987-04-22
Abstract: Compounds of formula: <IMAGE> Y is a halogen atom or a cyano or nitro group or an optionally halogenated alkyl or alkoxy group, n is a positive integer lower than 6 or zero, Tr denotes a 1,2,4-triazol-1-yl group and Im a 1,3-imidazol-1-yl group, R1 to R5 denote the halogen atom or a lower alkyl radical, X1 and X2 denote a halogen atom or a hydrocarbyl radical. Use of these compounds as fungicides especially against the disease of cereals and in arboriculture.
[EP0246982A2]
Patent IE-43113-L (IE)
Title: Anhydro-vinca alkaloids
IPC: C07D519/04
Filed: 1976-05-31
Abstract: Dimeric Vinca alkaloids are converted to three separable anhydro derivatives, useful as mitotic inhibitors or as intermediates for the preparation of other oncogenetically active alkaloids.
[US4029663A]
Patent IE-36658-L (IE)
Title: Steeplechase jumps.
IPC: A63K3/04
Filed: 1972-08-28
Abstract: 1395715 Steeplechase or like hurdles M HICKMAN and W H L STANHOPE 29 Aug 1972 [28 Aug 1971 2 June 1972] 40457/71 and 25816/72 Heading E1B A barrier for use as a steeplechase or other equestrian jump, or a simulated hedgerow, comprises a rigid framework including upstanding members 2, 4 inter-connected at or near their upper ends by transverse members 24 which are at least partly inclined to the horizontal, and which support plastics simulated twigs. The transverse members may have horizontal portions 24A, and may carry elongate horizontal twig holders 34, 36 thereacross having holes to receive the stems of twigs; alternatively the transverse members may carry an apertured tray to receive the twigs. A resilient bumper 56 may be attached to the barrier, as shown, and may comprise a polyurethane foam core covered by a plastics sheet.
[GB1395715A]
Patent IE-821311-L (IE)
Title: Preparation of 2-(thien-2-yl)-and-(thien-3-yl)ethylamines
IPC: C07D333/32
Filed: 1982-06-01
Abstract: The present invention provides a multistep process for the preparation of 2-(thien-2-yl)- and 2-(thien-3-yl)-ethylamine intermediates of the general formula:-    <IMAGE>  (I)  in which R1, in the 2-, 3-, 4- or 5-position, is a hydrogen or halogen atom, a nitro, amino, cyano or carboxyl group, a linear or branched alkyl or alkoxy radical or a heterocyclic or non-heterocyclic aromatic radical, which is optionally mono- or polysubstituted, R2 is a hydrogen atom, a linear or branched alkyl radical or a heterocyclic or non-heterocyclic aromatic radical, which is optionally mono- or polysubstituted, and Ar is a heterocyclic or non-heterocyclic aromatic radical, which is optionally mono- or polysubstituted, when the aminoethyl radical is in the two position and the radical R1 is in the 4- or 5-position, the above intermediates can be converted into 4,5,6,7-tetrahydrothieno[3,2-c]pyridine derivatives according to a procedure set forth in U.S. Pat. No. 4,127,580. When the aminoethyl radical is in the 3-position and the radical R1 is in the 4- or 5-position, the above intermediates can be converted into 4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives according to a procedure set forth in U.S. Pat. No. 4,127,580. Both sets of tetrahydrothieno pyridine final products possess anti-inflammatory, vasodilator and blood platelet aggregation inhibition activity.
Patent IE-901483-L (IE)
Title: HUMAN LACTOFERRIN cDNA SEQUENCE
IPC: C12N5/06
Filed: 1990-04-26
Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
Patent IE-39627-L (IE)
Title: Hair and skin protection
IPC: A61Q5/02
Filed: 1974-07-19
Abstract: The composition contains a non-enzymatic modified protein in combination with 0.1 to 90 % by weight of surface-active agent. The protein has an average molecular weight above 5000 and an isoionic point above pH 6. As the consequence of the modification, it contains one or more of the following functional groups: <IMAGE> In these, C, N, O and S denote carbon, nitrogen, oxygen and sulphur atoms respectively, which are part of the unmodified initial protein, and -Q, -W-, -X-, -Y- and -Z- have the meanings stated in Claim 1. The composition protects hair and skin against the damaging effects of aggressive materials, especially detergents, and against disadvantageous climatic conditions.
[GB1478014A]
Patent IE-37191-L (IE)
Title: Carpet sweeper
IPC: A47L11/33
Filed: 1972-11-23
Abstract: 1386957 Carpet sweepers PRESTIGE GROUP Ltd 29 Nov 1972 [1 Dec 1971] 55792/71 Heading A4F A carpet sweeper having a main brush 2, 3 rotatable about a substantially horizontal axis is provided with an auxiliary brush, comprising a stock 88 and circumferential extending rows of tufts 9, 10, and drive means for rotating it about an axis oblique to a horizontal plane and extending between horizontally spaced apart ends of the stock 88. As illustrated the auxiliary brush is driven from the main brush via a universal joint comprising a plastics extension 83 fitted on to a square sectioned end 82 of the main brush spindle 81 and into a cylindrical bore 89 of the brush stock 88. An end 86 of the extension 83 fits into a square sectioned bore portion in the brush stock 88 and has a projecting spindle 91 located in a recess 92 in a boss 93 on the sweeper casing 1. In an alternative embodiment the auxiliary brush stock 8, Fig. 1 (not shown) has a coaxial bore into which the main brush spindle extends, and the stock and spindle are coupled together by a disc member. An abutment may be provided to maintain the stock at a constant angle relative to the spindle. Other embodiments having differently constructed auxiliary brush stocks are described.
[GB1386957A]
Patent IE-821799-L (IE)
Title: Method of purifying n-benzyloxycarbonyl aspartic acid
IPC: C07C239/00
Filed: 1982-07-26
Abstract: N-benzyloxycarbonyl aspartic acid containing minor contaminating amounts of N-benzyloxycarbonyl aspartyl aspartic acid is purified by subjecting the impure material to alkaline hydrolysis at a pH of at least 10 and at temperatures of from 20 DEG C. to 100 DEG C., preferably 65 DEG C. to 85 DEG C., for a time sufficient to hydrolyze substantially all of the N-benzyloxycarbonyl aspartyl aspartic acid impurity therein. N-benzyloxycarbonyl aspartic acid containing less than 0.2 weight percent of the impurity can be obtained by such treatment.
[EP0072015A1]
Patent IE-802040-L (IE)
Title: Stylus printing head
IPC: B41J2/285
Filed: 1980-09-30
Abstract: A stylus printing head comprising a number of electromagnets which operate the printing styli and which are clamped on a conical carrier by means of a clamping device. The carrier comprises cradle-shaped, resilient supports for each of the electromagnets. The resilient supports compensate for differences in expansion of the electromagnets, the carrier and the clamping device in reaction to temperature variations occurring. The resilience of the supports is obtained by means of slots in the carrier which enable the use of a plurality of carriers in the same printing head.
[US4350450A]
Patent IE-902138-L (IE)
Title: Monokine activity interference
IPC: A61K31/445
Filed: 1990-06-13
Abstract: A method of treating a human afflicted with a T Cell Viral (TIV) infection, such as a human immunodeflciency virus (HIV) infection ,which comprises administering to such human an effective, monokine activity interfering amount of a monokine activity interfering agent.
[EP0403251A2]
Patent IE-44748-L (IE)
Title: Production of hydrated alumina
IPC: C01F7/06
Filed: 1976-10-19
Abstract: Process for treating solutions from the Bayer process, enabling amounts of sodium carbonate and sodium oxalate or sodium salts of organic acids corresponding to the amounts of these compounds dissolved during the attack on a bauxite to be removed by means of a barium compound, and without consumption of the latter.
[US4101629A]
Patent IE-812418-L (IE)
Title: Identification tag
IPC: A01K11/00
Filed: 1981-10-15
Abstract: A one piece identification tag which is formed from a flexible material. The tag comprises a panel on which identification indicia can be applied. A neck portion extends from the panel and terminates in a head portion. The head portion has a pair of flaps which project backwardly therefrom toward the panel with a flap being situated either side of the neck portion.
[US4739565A]
Patent IE-832505-L (IE)
Title: Microbial production of indigo
IPC: C12N15/09
Filed: 1983-10-26
Abstract: There is provided a DNA transformation vector comprising DNA sequences coding for microbial synthesis of an aromatic dioxygenase and tryptophanase enzymes, preferably wherein the DNA sequences are under the control of the same promoter/regulator DNA sequence.
Patent IE-872709-L (IE)
Title: Antibiotics
IPC: A61P31/04
Filed: 1987-10-09
Abstract: The present invention concerns new antiobiotic substances demoninated de-acyl antibiotics A40926, de-acyl antibiotic A 40926P and antibiotic A 40926 amino glucronyl aglycon, and the use of these substances in the treatment of infectious diseases involving microorganisms susceptible to it.
Patent IE-45082-L (IE)
Title: Derivatives of pyrimidone and thiopyrimidone
IPC: C07D217/12
Filed: 1976-12-22
Abstract: There is disclosed the preparation of compounds of the formula FORMULA 1 wherein Het is a 2- or 4-imidazolyl ring optionally substituted by lower alkyl (preferably methyl), halogen(preferably chlorine or bromine), trifluoromethyl or hydroxymethyl, a 2-pyridyl ring optionally substituted by lower alkyl (preferably methyl), lower alkoxy (preferably. methoxy), halogen (preferably chlorine or bromine), amino or hydroxy, a 2-thiazolyl ring, a 3-isothiazolyl ring optionally substituted by chlorine or bromine, a 3-(1,2,5)-thiadiazolyl ring optionally substituted by chlorine or bromine, or a 2-(5-amino-1,3,4-thiadiazolyl) ring; Y is sulphur or a methylene group; Z is hydrogen or lower alkyl(preferably methyl); X is oxygen or sulphur; W is methylene, oxygen or sulphur: p and q are such that their sum is from 1 to 4 when W is oxygen or sulphur, or from 0 to 4 when W is methylene; Het' is a 5 or 6 membered heterocycle such as pyridine, furan,thiophen, thiazole, oxazole, isothiazole, imidazole, pyrimidine, pyrazine or pyridazine,which ring is optionally substituted by lower alkyl, lower alkoxy, or may have a benzene ring or substituted benzene ring fused to it. The compounds have been found to be histamine H2- antagonists and are useful as inhibitors of gastric acid secrection, as antiinflammatory agents and as agents which act on the cardiovascular system.
[CA1073458A]
Patent IE-833060-L (IE)
Title: Purification of anthracycline glycosides
IPC: C07H15/24
Filed: 1983-12-23
Abstract: Disclosed is a process for purifying an impure anthracyclinone glycoside by selective adsorption of a slightly acidic aqueous solution of an impure glycoside on at least one resin and subsequent de-absorption of the purified glycoside by elution with acidic water or a mixture of water and a polar solvent.
[US4861870A]